Patients with severe COVID-19 are more likely to exhibit lymphopenia on admission, resulted in a broad immune cell reduction including CD4+ and CD8+ T cells, NK cells, and monocytes and dendritic cells. The gene discussed is CD4; the disease is COVID-19.